Colorectal Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for colorectal cancer.

Showing 19 trials

Title	Investigator
A Phase I Study of IMMU-130 in Patients with Colorectal Cancer [Protocol 11-074]	Segal, Neil, MD, PhD
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors [Protocol 12-224]	Segal, Neil, MD, PhD
A Phase I Study of MEDI3617 in Patients with Advanced Solid Tumors [Protocol 11-052]	Hyman, David, MD
A Phase I Study of TAS-102 plus CPT-11 (Irinotecan) in Patients with Advanced Digestive Cancers [Protocol 13-105]	Saltz, Leonard, MD
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors [Protocol 11-117]	Gounder, Mrinal, MD
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer [Protocol 10-137]	Kemeny, Nancy, MD
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2 [Protocol 13-140]	Solit, David, MD
A Pilot Evaluation of Radioimmunodetection of 124Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients with Colorectal Cancer [Protocol 03-124]	Larson, Steven, MD
A Pilot Study of Vemurafenib and Panitumumab in Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer [Protocol 12-221]	Yaeger, Rona, MD
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy [Protocol 11-194]	Ginex, Pamela, RN, EDD
A Study Comparing the Effectiveness of Virtual and Standard Colonoscopy for Colorectal Cancer Follow-up [Protocol 13-103]	Gollub, Marc, MD
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients [Protocol 04-144]	Stadler, Zsofia, MD
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery [Protocol 12-087]	Saltz, Leonard, MD
Clinical Significance of Germline BRCA Mutations [Protocol 96-051]	Offit, Kenneth, MD
Evaluating the Causes of Cancer in Young Patients [Protocol 09-068]	Stadler, Zsofia, MD
Examination of Tissue from Ablated Malignant Liver Metastases to Predict Outcome [Protocol 09-122]	Sofocleous, Constantinos, MD, PhD
Hereditary Colorectal Cancer Family Registry [Protocol 01-110]	Guillem, Jose, MD
ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Phase II Study of Early Post-Operative Abdominal Chemotherapy versus Heated Abdominal Chemotherapy for Cancers of the Appendix, Colon, or Rectum that Have Spread to the Abdominal Lining [Protocol 12-289]	Nash, Garrett, MD
The Sexual Health of Rectal Cancer Patients: A Pilot Study [Protocol 08-073]	DuHamel, Katherine, PhD

Recommended Links

National Cancer Institute: Questions to Ask About a Clinical Trials Web Site

Cancer.Net from ASCO: About Clinical Trials

National Comprehensive Cancer Network: Clinical Trials at Comprehensive Cancer Centers

American Cancer Society: What You Need to Know About Clinical Trials

Clinical Trials Home Page (Cancer.gov)